Manlangit, Shahanie H.
HRN: 21-96-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2022
CEFUROXIME 1.5GM (VIAL)
10/30/2022
11/07/2022
IV
1.5 G
Q8
Second Degree Laceration, Hepa B Reactive
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes